Skip to main content

and
  1. No Access

    Article

    An amoeba and a cyanobacterium walk into a bar...

    This Genome Watch highlights how studying endosymbiotic gene transfer in more recently established endosymbioses sheds light on how the algal plastid evolved more than a billion years ago.

    Bishoy Kamel, Alan Kuo in Nature Reviews Microbiology (2022)

  2. Article

    Open Access

    Elucidating gene expression adaptation of phylogenetically divergent coral holobionts under heat stress

    As coral reefs struggle to survive under climate change, it is crucial to know whether they have the capacity to withstand changing conditions, particularly increasing seawater temperatures. Thermal tolerance ...

    Viridiana Avila-Magaña, Bishoy Kamel, Michael DeSalvo in Nature Communications (2021)

  3. No Access

    Article

    Pharmacokinetics of Rosuvastatin: A Systematic Review of Randomised Controlled Trials in Healthy Adults

    Rosuvastatin is a lipid-lowering drug that works by inhibiting 3-hydroxy-3-methylglutaryl coenzyme A reductase, the rate-limiting enzyme responsible for producing cholesterol in humans. The pharmacokinetic dat...

    Raju Kanukula, Abdul Salam, Anthony Rodgers, Bishoy Kamel in Clinical Pharmacokinetics (2021)

  4. Article

    Open Access

    Correction: Corrigendum: Whole genome analysis of a schistosomiasis-transmitting freshwater snail

    Nature Communications 8: Article number: 15451 (2017); Published 16 May 2017; Updated 23 August 2017 The original version of this Article contained an error in the spelling of the author Leon Di Stefano, which...

    Coen M. Adema, LaDeana W. Hillier, Catherine S. Jones in Nature Communications (2017)

  5. Article

    Open Access

    Whole genome analysis of a schistosomiasis-transmitting freshwater snail

    Biomphalaria snails are instrumental in transmission of the human blood fluke Schistosoma mansoni. With the World Health Organization's goal to eliminate schistosomiasis as a global health problem by 2025, there ...

    Coen M. Adema, LaDeana W. Hillier, Catherine S. Jones in Nature Communications (2017)

  6. No Access

    Article

    Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat

    Febuxostat is a xanthine oxidoreductase inhibitor that has been developed to treat chronic gout. In healthy subjects, the pharmacokinetic parameters of febuxostat after multiple oral dose administration includ...

    Bishoy Kamel, Garry G. Graham, Kenneth M. Williams in Clinical Pharmacokinetics (2017)